Anastasia Voevodin
InvestorAnalyst, Public Equity at Sofinnova Ventures
About
Anastasia Voevodin joined Sofinnova BioEquities as an Analyst in 2024, where she focuses on public biotech investments. She previously worked as a Senior Research Associate at Avoro Capital covering public biotech, and as a management consultant at ZS Associates serving biotech clients. She holds a PhD in Chemistry from Columbia University and a BA in Chemistry with a Biomedical Engineering Science minor from Boston University.
Invests in
Biotech
Colleagues at Sofinnova Ventures
Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Partner at HealthQuest Capital
Frequently asked questions
- Who is Anastasia Voevodin?
- Anastasia Voevodin joined Sofinnova BioEquities as an Analyst in 2024, where she focuses on public biotech investments. She previously worked as a Senior Research Associate at Avoro Capital covering public biotech, and as a management consultant at ZS Associates serving biotech clients. She holds a PhD in Chemistry from Columbia University and a BA in Chemistry with a Biomedical Engineering Science minor from Boston University.
- Where does Anastasia Voevodin work?
- Anastasia Voevodin is Analyst, Public Equity at Sofinnova Ventures.
- What does Anastasia Voevodin invest in?
- Anastasia Voevodin invests in Biotech.